Brief: Mabion Signs Second Annex With Novavax On Omicron Variant

Mabion SA

06/04/2023 10:43

April 6 (Reuters) - Mabion SA  MABP.WA :
    * SIGNS SECOND ANNEX WITH NOVAVAX REGARDING POSSIBILITY FOR
NOVAVAX TO ORDER MANUFACTURE OF BATCHES OF COVID-19 VACCINE
ANTIGEN VARIANT OMICRON
    * UNDER ANNEX COMPANY TO MANUFACTURE PRODUCT, RUN ANALYTICAL
TESTING OF PRODUCT SAMPLES, STABILITY TESTS, SOURCE RAW
MATERIALS FOR PRODUCTION
    * COMPANY ALSO TO BE RESPONSIBLE FOR QUALITY MANAGEMENT AND
SUPERVISION, SUPPORT FOR NOVAVAX IN MEETING REGISTRATION
REQUIREMENTS BY PROVIDING RELEVANT DOCUMENTATION

Source text for Eikon:  ID:nEMbjcgtya 
Further company coverage:  MABP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))